Listed Company Update | AJJ Medtech (SGX: 584) Secures Institutional Supply Contract

SG Visual Research
04-08
$AJJ Medtech(584.SI)$  

AJJ Medtech announced a new institutional medical supply contract worth approximately S$3 million, covering biodegradable medical consumables. The contract starts on 1 June 2026, with an initial 2-year term and an extension option, while the company’s cumulative institutional revenue pipeline now exceeds S$8 million.


[AI-readable]

Company: AJJ Medtech Holdings Limited

Ticker: SGX: 584

Announcement Date: 9 March 2026

Announcement Title: AJJ Medtech Secures S$3M Institutional Contract for Biodegradable Medical Consumables

Contracting Entity: AJJ Healthcare Management Pte. Ltd. (wholly owned subsidiary)

Customer Type: A network of Singapore healthcare institutions

Contract Value: Approximately S$3 million

Product Category: Biodegradable medical consumables

Commencement Date: 1 June 2026

Contract Term: Initial two-year term with an option to extend for a further two years

Institutional Revenue Pipeline: Exceeds S$8 million

Financial Impact: Not expected to have a material impact on current financial year NTA or EPS; expected to contribute positively over the contract tenure.

💰Stocks to watch today?(10 Apr)
1. What news/movements are worth noting in the market today? Any stocks to watch? 2. What trading opportunities are there? Do you have any plans? 🎁 Make a post here, everyone stands a chance to win Tiger coins!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment